ROR2 and breast carcinoma: In detail, ROR2 overexpression promotes PI3K activation and AKT phosphorylation, followed by the downregulation of p21 and upregulation of cyclin D1 and PDK1, resulting in increased proliferation and survival of breast cancer cells [23].